Brenda Furlow

2021

In 2021, Brenda Furlow earned a total compensation of $4.5M as Executive Vice President and General Counsel at Bio-Techne, a 145% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$761,021
Option Awards$2,899,923
Salary$503,500
Stock Awards$299,836
Other$8,396
Total$4,472,676

Furlow received $2.9M in option awards, accounting for 65% of the total pay in 2021.

Furlow also received $761K in non-equity incentive plan, $503.5K in salary, $299.8K in stock awards and $8.4K in other compensation.

Rankings

In 2021, Brenda Furlow's compensation ranked 2,966th out of 12,415 executives tracked by ExecPay. In other words, Furlow earned more than 76.1% of executives.

ClassificationRankingPercentile
All
2,966
out of 12,415
76th
Division
Manufacturing
1,187
out of 5,505
78th
Major group
Chemicals And Allied Products
478
out of 2,375
80th
Industry group
Drugs
421
out of 2,096
80th
Industry
Biological Products, Except Diagnostic Substances
118
out of 449
74th
Source: SEC filing on September 14, 2022.

Furlow's colleagues

We found four more compensation records of executives who worked with Brenda Furlow at Bio-Techne in 2021.

2021

Charles Kummeth

Bio-Techne

Chief Executive Officer

2021

David Eansor

Bio-Techne

Former President, Protein Sciences

2021

James Hippel

Bio-Techne

Chief Financial Officer

2021

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

News

In-depth

You may also like